The Latest Breaking News from Influenza

LumiraDx Ltd (NASDAQ: LMDX) shares are trading higher by 10.31% at $4.28 after the company announced it achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete.

All except one of the positive cases were influenza type A.

Top End health authorities are feeling the strain as they scramble to deal with the worst flu outbreak in years.

Moderna, Inc. (NASDAQ: MRNA) today announced Initiation of Patient dosing in the phase 3 clinical study of its seasonal influenza vaccine candidate mRNA-1010 for patients with influenza.

Hong Kong has suspended the import of poultry from the UK in the latest consequence of an outbreak of avian influenza in the Shetland Islands.

The odds of a dangerous pathogen escaping a lab are uncertain, and have implications for COVID-19 and more

In a cruel reminder of the past two years, Albury High School had to go back to remote learning this week.

The Northern Territory has recorded its highest number of influenza cases in at least five years, putting significant pressure on an already stretched hospital system.

A Sunshine Coast GP says he expects the virus to reach epidemic levels in the coming months to put pressure on hospital and ambulance services.

Being up to date on COVID-19 vaccines means having had three or four doses of the same shot at this point. Current boosters are the same formulations as the first authorized shots, based on the original strain of the coronavirus that emerged in late 2019. They do still protect against…

Tasmania will offer free flu vaccinations at GPs and pharmacies for four weeks in response to a rising rate of influenza infections in the island state.